Scaled Investment Platform Expands Apollo's Origination Capabilities in Residential and Industrial Real Estate Bridge Manages $50 Billion of High-Quality AUM in Complementary Sectors Aligned with Apollo's Long-Term Growth Strategy NEW YORK and SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) and Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge” or the “Company”) today announced they have entered into a definitive agreement for Apollo to acquire Bridge in an all-stock transaction with an equity value of approximately $1.5 billion. Founded in 2009, Bridge is an established leader in residential and industrial real estate as well as other …

BELGRADE, Mont., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation's largest aerial firefighting companies, today announced that management is scheduled to participate in Canaccord and ROTH investor conferences in February and March 2025.

Expert-led 30-day program launches March 3 on the free Life Time app, featuring education, planning and recipes. CHANHASSEN, Minn.

Cheniere Energy's NYSE: LNG stock price uptrend can continue in 2025, and new highs can be set because of improving cash flow and capital returns. The company's business is supported by steadily rising natural gas demand globally and improving operational metrics that will be compounded by several new projects due to come online.

PARSIPPANY, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and fiscal year ended December 31, 2024, as well as recent business developments.

Boston (February 24, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific patient selection technology—the Drug Response Predictor (DRP®)—today announced that the new protocol for its Phase 2 clinical trial of stenoparib in ovarian cancer is set to begin and will be expected to provide critical data by end of summer 2026 for a pivotal registration trial.

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the full year 2024, after U.S. markets close on Wednesday, March 26, 2024. Following the release, Alvotech will conduct a conference call for analysts on Thursday, March 27, 2025, at 8:00 am ET (12 noon GMT). Live audio of the conference call will be webcast and available to members of the news media, investors and the general public.

Our analysis of Schlumberger offers favorable risk-reward opportunities by identifying the synergy between fundamentals and crowd behavior. Combining fundamental analysis with Elliott Wave Theory provides a comprehensive approach to stock valuation and market trends in stocks like SLB. The current analysis of SLB suggests a potential rally to new highs, with specific levels guiding and confirming future price movements.

5 th study arm in 12-week Phase 1b Study receives lead clinical site approval Kelowna, British Columbia – February 24, 2025 – TheNewswire - Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has received lead clinical site human research ethics committee (“HREC” ) approval that was required before dosing can begin in the 5 th study arm of the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, (the “ Study ”) in Australia.

SAN JOSE, Calif. , Feb. 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today is pleased to announce that its pioneering CAR-T therapy for ovarian cancer, developed in collaboration with Moffitt Cancer Center ("Moffitt"), was prominently featured in Breaking Cancer News in an article titled "Navigating Uncharted Territory: CAR-T for Ovarian Cancer.

HOUSTON--(BUSINESS WIRE)--Westlake Royal Building Products™ (“Westlake Royal”), a Westlake company (NYSE: WLK), has announced the expansion of Grove Collection™, a line of architectural PVC trim and mouldings, to include column wraps with caps and bases, a nickel gap profile and flat trim. Grove Collection combines the timeless charm and rich look of stained wood with the performance benefits of cellular PVC, making it perfect for enhancing outdoor living spaces, porch ceilings and soffits. Col.

REHOVOT, Israel , Feb. 24, 2025 /PRNewswire/ -- Nova (Nasdaq: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today announced that Guy Kizner, Chief Financial Officer will participate in the following investor conferences: Goldman Sachs European Technology Conference Format: In-person one-on-one meetings When: Wednesday, February 26 Location: London, UK Susquehanna's 14th Annual Technology Conference Format: Virtual one-on-one meetings When: Friday, February 28 Cantor Fitzgerald Global Technology Conference Format: In-person fireside chat and one-on-one meetings When: Tuesday, March 11, fireside chat at 8:40 am ET Location: New York, NY A …

Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J. , Feb. 24, 2025 /PRNewswire/ -- Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. In addition, …

—FDA Reaffirms Application is Under Priority Review with a PDUFA Target Action Date of August 12, 2025— BRIDGEWATER, N.J. , Feb. 24, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it does not currently plan to hold an advisory committee meeting to discuss the New Drug Application (NDA) for brensocatib for patients with non-cystic fibrosis bronchiectasis.

PARIS, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) announced its participation in ‘Project M-LightEn,' an ambitious new initiative to develop ultra-lightweight, sustainable vehicle chassis structures. Led by Gordon Murray Group (GMG), the initiative is supported by Innovate UK and the Advanced Propulsion Centre (APC), and includes as partners Constellium, Carbon ThreeSixty, and Brunel University London. Over the next three years, the consortium aims to achieve breakthrough innovations in unibody vehicle architecture that reduce carbon intensity by 50% while being 25% lighter.

MORRISTOWN, N.J. , Feb. 24, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) announced today its presentation at the TD Cowen 45th Annual Healthcare Conference, taking place March 3-5, 2025, in Boston, MA.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader.

�ZURICH, Feb. 24, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX:AMC), a global leader in developing and producing responsible packaging solutions will present at the at the Bank of America 2025 Global Agriculture and Materials Conference on Wednesday February 26, 2025. Amcor's CEO Peter Konieczny and CFO Michael Casamento are scheduled to participate in a fireside chat at 1.15pm Eastern time.

BEIJING , Feb. 24, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that its innovative Tianmu Insurance Anti-Fraud and Risk Control Model has been recognized in the prestigious Top 100 AI Products of 2024 list, released by Internet Weekly in collaboration with eNET Research Institute and Deben Consulting. This accolade highlights Cheche's commitment to leveraging cutting-edge technology in the insurance industry.

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Feb 17, 2025 to Feb 21, 2025 AMSTERDAM – February 24, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024.